Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 333
1.
Med Mycol ; 2024 May 14.
Article En | MEDLINE | ID: mdl-38744661

The Second International Meeting on Endemic Mycoses of the Americas (IMEMA) and the First International Symposium on Implantation Mycoses (ISIM) took place in Santiago del Estero, Argentina during September 25-27th, 2023. The conference provided a platform for researchers, clinicians, and experts to discuss the latest developments in the field of endemic and implantation mycoses. Topics included epidemiology, diagnostic advances, treatment strategies, and the impact of environmental factors in the spread of these fungal diseases. IMEMA and ISIM contributed to the regional discourse on the mycoses, emphasizing the importance of international cooperation in addressing these public health challenges.


IMEMA/ISIM, held in Santiago del Estero, Argentina, convened experts to discuss endemic and implantation mycoses, covering topics such as epidemiology, diagnostics, treatment, and advocacy. The event highlighted ongoing efforts in combating these diseases.

2.
Medicina (B Aires) ; 83(6): 863-874, 2023.
Article En | MEDLINE | ID: mdl-38117705

INTRODUCTION: Histoplasmosis is a systemic mycosis of universal distribution, highly endemic in the Americas. It is caused by a dimorphic fungus Histoplasma capsulatum var. capsulatum. It affects both immunocompetent and immunocompromised individuals where progressive and disseminated forms are observed. A very important risk factor is HIV infection/AIDS, with a mortality rate of 20-40% in Latin America. The diagnosis of this mycosis is made by conventional and molecular methods or by antigen and antibody detection. METHODS: In this retrospective, longitudinal and analytical study, carried out over a period of 2 years, the sensitivity (S) and specificity (E) of a commercial kit for the detection of Histoplasma antigen by EIA technique (HC-Ag) was evaluated in 50 patients with AIDSassociated histoplasmosis. In addition, its performance was compared with that of other diagnostic techniques routinely used in our laboratory. RESULTS: HC-Ag had a S of 94%, E 96%, positive likelihood coefficient (CVP): 20.68 and negative likelihood coefficient (CVN): 0.06. The delay time of the results was 4 days, similar to that of antibody detection and n-PCR and much less than that of blood cultures. The combination of methods improved S to 100%; with similar values in E. CONCLUSION: The HC-Ag method demonstrated its usefulness in the diagnosis of progressive disseminated histoplasmosis and the combination of methods is a good option to increase sensitivity and decrease the time to reach the diagnosis of certainty. This allows improving the strategy in the management of the disease and decreasing its case-fatality rate.


Introducción: La histoplasmosis es una micosis sistémica de distribución universal, altamente endémica en las Américas. Es causada por un hongo dimórfico: Histoplasma capsulatum var. capsulatum. Afecta tanto a inmunocompetentes como a inmunocomprometidos, se observan formas progresivas y diseminadas. Un factor de riesgo muy importante es la infección por HIV/sida, con una tasa de mortalidad del 20-40% en América Latina. El diagnóstico de esta micosis se realiza por métodos convencionales y moleculares o por detección de antígenos y anticuerpos. Métodos: En este estudio retrospectivo, longitudinal y analítico, realizado en un periodo de 2 años, se evaluó la sensibilidad (S) y especificidad (E) de un kit comercial para la detección de antígeno de Histoplasma por técnica de EIA (HC-Ag) en 50 pacientes con histoplasmosis asociada a sida. Además, se comparó su rendimiento con el de otras técnicas diagnósticas utilizadas habitualmente en nuestro laboratorio. Resultados: HC-Ag tuvo una S del 94%, E del 96%, coeficiente de verosimilitud positiva (CVP) de 20.68 y coeficiente de verosimilitud negativa (CVN) de 0.06. El tiempo de demora de los resultados fue de 4 días, similar al de la detección de anticuerpos y n-PCR y mucho menor que el de los hemocultivos. La combinación de métodos mejoró la S a 100%; con valores similares en E. Conclusión: El método HC-Ag demostró su utilidad en el diagnóstico de histoplasmosis diseminada progresiva y la combinación de métodos es una buena opción para aumentar la sensibilidad y disminuir el tiempo para llegar al diagnóstico de certeza. Esto permite mejorar la estrategia en el manejo de la enfermedad y reducir su tasa de letalidad.


HIV Infections , Histoplasmosis , Humans , Histoplasmosis/diagnosis , Histoplasma , Retrospective Studies , Argentina/epidemiology , Immunoenzyme Techniques , Antigens, Fungal/analysis
3.
Rev Iberoam Micol ; 40(2-3): 35-38, 2023.
Article Es | MEDLINE | ID: mdl-37978018

We present the case of a twenty six year-old woman with rheumatoid arthritis, treated with certolizumab. She sought medical attention due to cough, fever and night sweats. X-ray exam showed a miliary pneumonia. She was treated for tuberculosis and 50days later she presented with aphasia. Magnetic nuclear resonance revealed brain lesions. Histoplasma capsulatum PCR test and urinary antigen were positive, so an antifungal treatment with voriconazole was started. Visual adverse effects forced to change the antifungal schedule in both the length of treatment and the antifungal drug. With this measure the patient progressed favorably. The test of urinary Histoplasma capsulatum antigen and PCR amplification were key to make a diagnosis and also for a follow-up.


Antifungal Agents , Histoplasmosis , Female , Humans , Adult , Antifungal Agents/therapeutic use , Antifungal Agents/pharmacology , Histoplasmosis/complications , Histoplasmosis/diagnosis , Histoplasmosis/drug therapy , Mycology , Histoplasma , Voriconazole/pharmacology
4.
Rev. iberoam. micol ; 40(2/3): 35-38, Abr-Jun, 2023. ilus
Article Es | IBECS | ID: ibc-228373

We present the case of a twenty six year-old woman with rheumatoid arthritis, treated with certolizumab. She sought medical attention due to cough, fever and night sweats. X-ray exam showed a miliary pneumonia. She was treated for tuberculosis and 50days later she presented with aphasia. Magnetic nuclear resonance revealed brain lesions. Histoplasma capsulatum PCR test and urinary antigen were positive, so an antifungal treatment with voriconazole was started. Visual adverse effects forced to change the antifungal schedule in both the length of treatment and the antifungal drug. With this measure the patient progressed favorably. The test of urinary Histoplasma capsulatum antigen and PCR amplification were key to make a diagnosis and also for a follow-up.(AU)


Se presenta el caso de una paciente de 26años de edad, profesora de educación física. Nació y vive en Burzaco, conurbano sur de la Provincia de Buenos Aires, República Argentina. Debido a su trabajo había realizado diversos viajes y acampado en diferentes provincias de nuestro país (Misiones, Corrientes, San Juan y Mendoza). En el extranjero solo había visitado Orlando (EE.UU.). Desde hacía 10años padecía artritis reumatoide juvenil. Por esta patología recibió metotrexato 15mg/semana, prednisona 5mg/día e hidroxicloroquina 400mg/día durante 7años. Posteriormente le fue prescrito certolizumab 200mg cada dos semanas y, posteriormente, 400mg cada cuatro semanas. Tras dos años con esta medicación le fue suspendida por la aparición de tos seca, fiebre, astenia, adinamia y sudores nocturnos. Debido a estas manifestaciones se le realizó una radiografía de tórax (fig. 1) y se suspendió inmediatamente el tratamiento con el inmunomodulador (certolizumab).(AU)


Humans , Female , Adult , Methotrexate/administration & dosage , Arthritis, Juvenile/drug therapy , Prednisone/administration & dosage , Hydroxychloroquine/adverse effects , Paracoccidioides , Histoplasmosis/complications , Mycology/trends , Treatment Outcome , Cough , Asthenia , Fever , Radiography, Thoracic , Antifungal Agents , Patient Dropouts , Histoplasmosis/diagnosis , Histoplasmosis/drug therapy
5.
J Fungi (Basel) ; 9(3)2023 Mar 14.
Article En | MEDLINE | ID: mdl-36983522

Sporotrichosis is the main subcutaneous mycosis worldwide transmitted by animal or plant vectors and often escalates to outbreaks or epidemics. The current cat-transmitted sporotrichosis driven by Sporothrix brasiliensis has become a significant public health issue in South America. Transmission dynamics remain enigmatic due to the lack of development of polymorphic markers for molecular epidemiological analysis. This study used a high-throughput mining strategy to characterize simple sequence repeat (SSR) markers from Sporothrix genomes. A total of 118,140-143,912 SSR loci were identified (82,841-98,369 unique markers), with a 3651.55-3804.65 SSR/Mb density and a majority of dinucleotides motifs (GC/CG). We developed a panel of 15 highly polymorphic SSR markers suitable for genotyping S. brasiliensis, S. schenckii, and S. globosa. PCR amplification revealed 240 alleles in 180 Sporothrix isolates with excellent polymorphic information content (PIC = 0.9101), expected heterozygosity (H = 0.9159), and discriminating power (D = 0.7127), supporting the effectiveness of SSR markers in uncovering cryptic genetic diversity. A systematic population genetic study estimated three clusters, corresponding to S. brasiliensis (population 1, n = 97), S. schenckii (population 2, n = 49), and S. globosa (population 3, n = 34), with a weak signature of mixed ancestry between populations 1 and 2 or 3 and 2. Partitioning of genetic variation via AMOVA revealed highly structured populations (ΦPT = 0.539; Nm = 0.213; p < 0.0001), with approximately equivalent genetic variability within (46%) and between (54%) populations. Analysis of SSR diversity supports Rio de Janeiro (RJ) as the center of origin for contemporary S. brasiliensis infections. The recent emergence of cat-transmitted sporotrichosis in northeastern Brazil indicates an RJ-Northeast migration resulting in founder effects during the introduction of diseased animals into sporotrichosis-free areas. Our results demonstrated high cross-species transferability, reproducibility, and informativeness of SSR genetic markers, helping dissect deep and fine-scale genetic structures and guiding decision making to mitigate the harmful effects of the expansion of cat-transmitted sporotrichosis.

6.
Actual. SIDA. infectol ; 30(109): 38-47, 20220000. tab, fig
Article Es | LILACS, BINACIS | ID: biblio-1392519

La criptococosis es una micosis grave que se manifiesta, en el 90% de los casos, como una meningoencefalitis, especialmente en las personas con VIH. El objetivo de este estudio es describir los casos de criptococosis extrameníngea en personas viviendo con VIH y conocer cuántas de estas padecen compromiso meníngeo concomitante. Además, determinar la relación con el título de antígeno polisacárido capsular de Cryptococcus en suero. Se realizó un estudio retrospectivo, observacional y analítico. Se incluyeron personas viviendo con VIH cuyo diagnóstico inicial de criptococosis se había realizado a partir de muestras extrameníngeas en el período comprendido entre 2012 y 2019. Los pacientes se dividieron en dos grupos. Grupo 1, pacientes sin compromiso meníngeo; Grupo 2, aquellos que finalmente tenían compromiso del SNC. De un total de 531 criptococosis registradas en ese período, se incluyeron 113 pacientes (21%), de los cuales en 58 se comprobó el compromiso meníngeo. No se observaron diferencias significativas en cuanto a la mortalidad entre ambos grupos.Ninguno de los pacientes con antigenemia por LFA (antígeno capsular en suero por inmunocromatografía) positiva, pero con antigenemia por aglutinación de partículas de látex (AL) negativa, tuvo compromiso meníngeo. Se observó que títulos de antígeno para Cryptococcus en suero por AL mayor o igual a 1/100 se correlacionaron con un aumento de 30 veces en la posibilidad de padecer meningitis. En todos los casos se debe descartar el compromiso del SNC. La AL sigue siendo una prueba útil y complementaria, debido a que en los casos con AL negativa no se observó compromiso meníngeo


Cryptococcosis is a serious mycosis that manifests itself, in 90% of cases, as meningoencephalitis, especially in AIDS patients. The objective of this study is to describe the extra-meningeal cases of cryptococcosis in people living with HIV and to know how many of them suffer from concomitant meningeal involvement. Also, to determine its relationship with the Cryptococcus capsular polysaccharide antigen titer in serum.A retrospective, observational and analytical study was carried out. HIV-positive patients whose initial diagnosis had been made from extrameningeal samples in the period between 2012 and 2019 were included. The patients were divided into 2 groups. Group 1: patients without meningeal involvement; group 2: those who finally had CNS involvement.Of a total of 531 cryptococcosis registered in this period, 113 patients (21%) were included, of whom meningeal involvement was confirmed in 58. No significant differences were observed in terms of mortality in both groups.None of the patients with positive LFA antigenemia (Capsular antigen detection by lateral Flow assay) but negative latex particle agglutination (LA) antigenemia had meningeal involvement. LFA was found to be highly sensitive and allows early diagnosis, but it does not replace other diagnostic procedures.Serum Cryptococcus antigen titers for by LA greater than or equal to 1/100 were found to correlate with a 30-fold increase in the likelihood of meningitis.In all cases, CNS involvement must be ruled out. LA continues to be a useful and complementary test, because in cases with negative LA, no meningeal involvement was observed


Humans , Spinal Puncture , Concurrent Symptoms , Retrospective Studies , Chromatography, Affinity/statistics & numerical data , HIV/immunology , Cryptococcosis/diagnosis , Cryptococcosis/therapy , Point-of-Care Testing
7.
Fungal Biol ; 125(10): 834-843, 2021 10.
Article En | MEDLINE | ID: mdl-34537179

Sporothrix schenckii and allied species are thermodimorphic fungi widely distributed in nature which causes human and animal sporotrichosis, the most common subcutaneous mycosis globally. Sporotrichosis is acquired after a traumatic inoculation of soil or plant material contaminated with Sporothrix propagules or through bites and scratches from diseased cats. In Ascomycota, the master regulators of sex are MAT genes that lie in a single mating-type locus, in Sporothrix these are determined by two nonhomologous alleles, MAT1-1 and MAT1-2. We assessed the whole-genome sequences of medically relevant Sporothrix to develop a single-tube duplex PCR assay to screen S. brasiliensis, S. schenckii, S. globosa, and S. luriei idiomorphs (MAT1-1 or MAT1-2) and understand the distribution and incidence of mating-type strains from natural populations. Using our duplex PCR assay, a 673 bp amplicon (α-box protein) was consistently amplified from all MAT1-1 isolates, while a 291 bp fragment was only amplified from the isolates harboring MAT1-2 (HMG box). Molecular evidence suggests heterothallism (self-sterility) as the unique mating strategy among the species evaluated. The mating-type identity of 93 isolates revealed a nearly equal distribution (1:1 ratio) of mating type alleles within species but deviating between different outbreak areas. Remarkably, for S. brasiliensis in Rio de Janeiro, we report an overwhelming occurrence of MAT1-2 (1:13 ratio; χ2 = 10.286, P = 0.0013) opposing the high prevalence MAT1-1 in the Rio Grande do Sul (10:1 ratio; χ2 = 7.364, P = 0.0067). Therefore, the population structure of Sporothrix species refers from paucity to regular cycles of sexual recombination in most of the studied regions. Our PCR-based mating-type diagnostic assay is proposed here as an important marker to track the geographical expansion during the long-lasting outbreak of cat-transmitted sporotrichosis driven by S. brasiliensis.


Sporothrix , Sporotrichosis , Animals , Brazil , Polymerase Chain Reaction , Sporothrix/genetics , Sporotrichosis/epidemiology , Sporotrichosis/veterinary
8.
Rev Iberoam Micol ; 38(3): 132-137, 2021.
Article En | MEDLINE | ID: mdl-34092515

BACKGROUND: Recurrent vulvovaginitis is a growing problem that affects millions of women worldwide. In many cases it is treated as vulvovaginal candidiasis, but there is not always microbiological confirmation. AIMS: To determine the etiology of vulvovaginitis in a group of patients. METHODS: This is a cross-sectional study in which the data from the medical records of 316 adult patients who consulted for vulvovaginitis were analyzed. Eighty nine percent of the cases had already suffered previous episodes. RESULTS: The median age was 34 (265 patients were between 16 and 45 years old). Yeasts were isolated in culture from 211 (66.8%) patients, although pseudo-hyphae and yeasts were observed in only 166 samples (52.5%) in the direct microscopic examination. Multiple predisposing factors were found, among which the use of contraceptives or previous antibiotics stand out. Most of the patients (almost 90%) had been treated with antifungals, with or without microbiological confirmation. Candida albicans was isolated in 187 (88.6%) patients, followed by Candida glabrata in 6 (2.8%) patients. Association with bacterial vaginosis was found in 35.1% and with intermediate bacterial microbiota in 33.2% of the cases. A remarkably high proportion of C. albicans isolates resistant to fluconazole (80.1%) and itraconazole (58.8%) was found. CONCLUSIONS: A microbiological analysis is essential to confirm the diagnosis of vulvovaginal candidiasis, whether simple, complicated, or recurrent. Identifying the isolated yeast species and determining its susceptibility to antifungal agents are particularly important.


Candidiasis, Vulvovaginal , Vulvovaginitis , Adult , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Candida , Candidiasis, Vulvovaginal/drug therapy , Candidiasis, Vulvovaginal/epidemiology , Cross-Sectional Studies , Drug Resistance, Fungal , Female , Fluconazole , Humans , Microbial Sensitivity Tests , Vulvovaginitis/drug therapy , Vulvovaginitis/epidemiology
9.
Rev. iberoam. micol ; 38(1): 19-22, ene.-mar. 2021. ilus, tab
Article En | IBECS | ID: ibc-202394

BACKGROUND: Cryptococcosis is a severe universally distributed mycosis which mainly affects immunocompromised hosts. This mycosis is caused by yeasts of two species complex of the genus Cryptococcus: Cryptococcus neoformans and Cryptococcus gattii. Meningeal cryptococcosis is the most frequent clinical presentation of this disseminated mycosis. The oral mucosa involvement is extremely unusual. CASE REPORT: We present a case of cryptococcosis with an unusual clinical form. The patient was assisted because she had an ulcerated lesion on the lingual mucosa. Encapsulated yeasts compatible with Cryptococcus were found in microscopic exams of wet preparations from lingual ulcer clinical samples obtained for cytodiagnosis and mycological studies. Cryptococcus neoformans (C. neoformans var. grubii VNI) was isolated in culture. This patient did not know her condition of HIV seropositive before the appearance of the tongue lesion. CONCLUSIONS: The involvement of the oral mucosa is uncommon in this fungal infection, but is important to include it in the differential diagnosis in HIV positive patients


ANTECEDENTES: La criptococosis es una micosis grave de distribución universal que afecta principalmente a los huéspedes inmunodeficientes. Se han definido dos complejos de especies patógenas: Cryptococcus neoformans y Cryptococcus gattii. La meningoencefalitis es la presentación clínica más frecuente de esta micosis sistémica. La afectación de la mucosa oral es extremadamente rara. CASO CLÍNICO: Presentamos el caso de una paciente VIH positiva con una forma clínica inusual de criptococosis. La enferma presentaba una lesión ulcerada en la punta de la lengua. El examen microscópico en fresco de la escarificación y de la biopsia de esta lesión mostraron levaduras capsuladas compatibles con Cryptococcus. Se obtuvo Cryptococcus neoformans (C. neoformans var. grubii VNI) en los cultivos. La paciente conoció su estado inmunológico (infección por VIH) en el contexto de esta enfermedad oportunista. CONCLUSIONES: La afectación de la mucosa oral es poco común en esta infección fúngica, pero es importante incluirla en el diagnóstico diferencial en pacientes VIH positivos


Humans , Female , Adult , Cryptococcosis/diagnosis , HIV Infections/complications , Tongue/pathology , Cryptococcosis/drug therapy , Cryptococcosis/microbiology , Cryptococcus neoformans/isolation & purification , Cryptococcus neoformans/virology , Tongue/microbiology , Mouth Mucosa/microbiology , Diagnosis, Differential , Microscopy/methods , Trimethoprim/administration & dosage , Sulfamethoxazole/administration & dosage , Anti-Retroviral Agents/administration & dosage
10.
Rev Argent Microbiol ; 53(4): 309-313, 2021.
Article Es | MEDLINE | ID: mdl-33618899

A descriptive observational and cross-sectional study was carried out. The clinical characteristics, etiologic agents, treatments and outcome of 33 cases of tinea capitis in the Mycology Unit at Francisco J. Muñiz Hospital of Buenos Aires City between January 2015 and December 2019 were analyzed. The median age of the patients was 7 years, 21 of whom were male, 3 were HIV-positive and 22 had pets. The isolated etiologic agents were the following: Microsporum canis in 22 cases, Trichophyton tonsurans in 8, Nannizzia gypsea in 2 and Trichophyton mentagrophytes in one patient. Suppurative tinea capitis (krion Celsi) was detected in 10 cases and the same number of patients presented other skin locations of their dermatophytosis in addition to those in the scalp. Twenty-one cases were orally treated with griseofulvin and 12 with terbinafine. Those patients with suppurative tinea capitis received drops of betamethasone by mouth besides the antifungal drugs. All patients had good clinical and mycological response to the treatments, all lesions disappeared, and mycological studies turned negative by the end of the treatments. We conclude that both drugs were effective for the treatment of tinea capitis; however, lesions in those cases receiving terbinafine involuted more slowly.


Naphthalenes , Tinea Capitis , Antifungal Agents/therapeutic use , Child , Cross-Sectional Studies , Griseofulvin/therapeutic use , Humans , Male , Terbinafine/therapeutic use , Tinea Capitis/diagnosis , Tinea Capitis/drug therapy , Tinea Capitis/epidemiology , Trichophyton
11.
Rev Iberoam Micol ; 38(1): 19-22, 2021.
Article En | MEDLINE | ID: mdl-33388240

BACKGROUND: Cryptococcosis is a severe universally distributed mycosis which mainly affects immunocompromised hosts. This mycosis is caused by yeasts of two species complex of the genus Cryptococcus: Cryptococcus neoformans and Cryptococcus gattii. Meningeal cryptococcosis is the most frequent clinical presentation of this disseminated mycosis. The oral mucosa involvement is extremely unusual. CASE REPORT: We present a case of cryptococcosis with an unusual clinical form. The patient was assisted because she had an ulcerated lesion on the lingual mucosa. Encapsulated yeasts compatible with Cryptococcus were found in microscopic exams of wet preparations from lingual ulcer clinical samples obtained for cytodiagnosis and mycological studies. Cryptococcus neoformans (C. neoformans var. grubii VNI) was isolated in culture. This patient did not know her condition of HIV seropositive before the appearance of the tongue lesion. CONCLUSIONS: The involvement of the oral mucosa is uncommon in this fungal infection, but is important to include it in the differential diagnosis in HIV positive patients.


Cryptococcosis , Cryptococcus gattii , Cryptococcus neoformans , HIV Seropositivity , Cryptococcosis/complications , Cryptococcosis/diagnosis , Female , Humans , Tongue
12.
Rev. iberoam. micol ; 37(3/4): 107-109, jul.-oct. 2020. ilus
Article Es | IBECS | ID: ibc-200363

No disponible


A 26 year_old woman, who had been submmited to a classic cholecystectomy for a lithic cholecystitis, was admitted in the Hepathology Unit of the F. J. Muniz Hospital of Buenos Aires City, due to persistent jaundice, weight loss, asthenia, arterial hypotension, ascites and periumbilical ulcer. These skin lesions were located under an adhesive tape which was around a Kehr tube. Laboratory studies showed anemia, hyperbilirrubinemia, increased level of hepatic enzymes and a positive anti-mitochondrial antibodies test 1/80. The diagnosis of her liver disease was autoimmune hepatitis and the patient received corticosteroid treatment by oral route. The microbiological study of the skin lesions showed hyaline, wide, non_septate hyphae in the microscopic study, and Rhizopus arrhizus was isolated in cultures. Colloidal dispersion of amphotericin B at a daily dose of 5 mg/kg intravenously was administered and a surgical debridement of the cutaneous lesions was done. Skin lesions improved with this treatment, but her hepatic condition turned worse and evolved to a fatal hepatic insufficiency. She could not receive a liver transplant due to the lack of a compatible donor


Humans , Female , Adult , Hepatitis, Autoimmune/drug therapy , Prednisone/adverse effects , Prednisone/therapeutic use , Glucocorticoids/adverse effects , Glucocorticoids/therapeutic use , Fatal Outcome
14.
Fungal Genet Biol ; 140: 103395, 2020 07.
Article En | MEDLINE | ID: mdl-32325168

Paracoccidioidomycosis (PCM) is a life-threatening systemic mycosis widely reported in the Gran Chaco ecosystem. The disease is caused by different species from the genus Paracoccidioides, which are all endemic to South and Central America. Here, we sequenced and analyzed 31 isolates of Paracoccidioides across South America, with particular focus on isolates from Argentina and Paraguay. The de novo sequenced isolates were compared with publicly available genomes. Phylogenetics and population genomics revealed that PCM in Argentina and Paraguay is caused by three distinct Paracoccidioides genotypes, P. brasiliensis (S1a and S1b) and P. restrepiensis (PS3). P. brasiliensis S1a isolates from Argentina are frequently associated with chronic forms of the disease. Our results suggest the existence of extensive molecular polymorphism among Paracoccidioides species, and provide a framework to begin to dissect the connection between genotypic differences in the pathogen and the clinical outcomes of the disease.


Genetic Variation/genetics , Genomics , Paracoccidioides/genetics , Paracoccidioidomycosis/genetics , Argentina/epidemiology , Ecosystem , Genetics, Population , Genome, Fungal/genetics , Genotype , Humans , Paracoccidioides/classification , Paracoccidioides/pathogenicity , Paracoccidioidomycosis/classification , Paracoccidioidomycosis/epidemiology , Paracoccidioidomycosis/microbiology , Paraguay/epidemiology , Phylogeny
15.
J Clin Immunol ; 40(2): 359-366, 2020 02.
Article En | MEDLINE | ID: mdl-31940125

PURPOSE: Caspase-associated recruitment domain-9 (CARD9) deficiency is an inborn error of immunity that typically predisposes otherwise healthy patients to single fungal infections and the occurrence of multiple invasive fungal infections is rare. It has been described as the first known condition that predisposes to extrapulmonary Aspergillus infection with preserved lungs. We present a patient that expands the clinical variability of CARD9 deficiency. MATERIALS AND METHODS: Genetic analysis was performed by Sanger sequencing. Neutrophils and mononuclear phagocyte response to fungal stimulation were evaluated through luminol-enhanced chemiluminescence and whole blood production of the proinflammatory mediator interleukin (IL)-6, respectively. RESULTS: We report a 56-year-old Argentinean woman, whose invasive Exophiala spinifera infection at the age of 32 years was unexplained and reported in year 2004. At the age of 49 years, she presented with chronic pulmonary disease due to Aspergillus nomius. After partial improvement following treatment with caspofungin and posaconazole, right pulmonary bilobectomy was performed. Despite administration of multiple courses of antifungals, sustained clinical remission could not be achieved. We recently found that the patient's blood showed an impaired production of IL-6 when stimulated with zymosan. We also found that she is homozygous for a previously reported CARD9 loss-of-function mutation (Q289*). CONCLUSIONS: This is the first report of a patient with inherited CARD9 deficiency and chronic invasive pulmonary aspergillosis (IPA) due to A. nomius. Inherited CARD9 deficiency should be considered in otherwise healthy children and adults with one or more invasive fungal diseases.


Aspergillus/physiology , CARD Signaling Adaptor Proteins/genetics , Candidiasis, Chronic Mucocutaneous/diagnosis , Exophiala/physiology , Mutation/genetics , Phaeohyphomycosis/diagnosis , Pulmonary Aspergillosis/diagnosis , Candidiasis, Chronic Mucocutaneous/genetics , Cells, Cultured , Female , Humans , Interleukin-6/metabolism , Middle Aged , Pedigree , Phaeohyphomycosis/genetics , Pneumonectomy , Pulmonary Aspergillosis/genetics
16.
Rev. iberoam. micol ; 36(2): 93-95, abr.-jun. 2019. ilus
Article Es | IBECS | ID: ibc-185484

Paciente de 21 años, de sexo masculino, infectado por el VIH y que no sigue adecuadamente el tratamiento antirretroviral, que acude a consulta debido a una erupción papular en el tronco y las extremidades, acompañada de manera simultánea por manchas hipocrómicas en la espalda. El paciente estaba afebril y hemodinámicamente estable. En el estudio micológico de las muestras clínicas de diferentes lesiones se observaron levaduras compatibles con Malassezia. Se prescribió itraconazol por vía oral, con una excelente respuesta clínica. El hallazgo del mismo agente etiológico con 2 presentaciones clínicas diferentes en un solo paciente es poco habitual


A 21 year-old man, HIV infected, and with poor adherence to antiretroviral treatment, consulted us due to a papular rash on trunk and extremities, showing simultaneously hypochromic stains on his back. He was afebrile and hemodynamically stable. In the mycological study of the clinical samples taken from different lesions, yeasts compatible with Malassezia were observed. Oral itraconazole was prescribed, with an excellent clinical response. Finding the same etiolologic agent in 2 different clinical pictures on a single patient is extremely rare


Humans , Male , Young Adult , Dermatomycoses/microbiology , HIV Infections/microbiology , Malassezia/isolation & purification , Administration, Oral , Antifungal Agents/administration & dosage , Dermatomycoses/drug therapy , Itraconazole/administration & dosage , Pigmentation Disorders/microbiology
17.
J Fungi (Basel) ; 5(2)2019 May 21.
Article En | MEDLINE | ID: mdl-31117260

Aspergillosis is a set of very frequent and widely distributed opportunistic diseases. Azoles are the first choice for most clinical forms. However, the distribution of azole-resistant strains is not well known around the world, especially in developing countries. The aim of our study was to determine the proportion of non-wild type strains among the clinical isolates of Aspergillus spp. To this end, the minimum inhibitory concentration of three azoles and amphotericin B (used occasionally in severe forms) was studied by broth microdilution. Unexpectedly, it was found that 8.1% of the isolates studied have a diminished susceptibility to itraconazole. This value turned out to be similar to the highest azole resistance rate reported in different countries across the world.

18.
Rev Iberoam Micol ; 36(2): 93-95, 2019.
Article Es | MEDLINE | ID: mdl-30862391

A 21 year-old man, HIV infected, and with poor adherence to antiretroviral treatment, consulted us due to a papular rash on trunk and extremities, showing simultaneously hypochromic stains on his back. He was afebrile and hemodynamically stable. In the mycological study of the clinical samples taken from different lesions, yeasts compatible with Malassezia were observed. Oral itraconazole was prescribed, with an excellent clinical response. Finding the same etiolologic agent in 2different clinical pictures on a single patient is extremely rare.


Dermatomycoses/microbiology , HIV Infections/microbiology , Malassezia/isolation & purification , Administration, Oral , Antifungal Agents/administration & dosage , Dermatomycoses/drug therapy , Humans , Itraconazole/administration & dosage , Male , Pigmentation Disorders/microbiology , Young Adult
19.
Rev. iberoam. micol ; 35(1): 1-10, ene.-mar. 2018. tab, graf
Article En | IBECS | ID: ibc-170915

Background. Cryptococcosis is still a life-threatening mycosis that continues to be of serious concern in Latin American countries, especially among HIV+positive population. However, there is not any reliable information about the prevalence of this disease in this region. Aims. The aim of this study is to report data of 2041 patients with cryptococcosis that were attended at the Infectious Diseases Hospital F. J. Muñiz over a 30 year-period. Methods. Information about demographic and clinical data, survival time and the applied treatment, was taken from the Mycology Unit database. Mycological exams from different clinical samples were performed. Cryptococcal capsular antigen in serum and cerebrospinal fluid was detected through the latex agglutination technique. Cryptococcus isolates were phenotypically identified and the genotype was determined in some of them. Susceptibility tests were carried out following M27-A3 document. Results. Seventy five percent of HIV+positive patients and 50% of the HIV-negative population were males. Mean ages were 34.1 in HIV+positive patients and 44.8 in the HIV-negative. Cryptococcosis was associated with AIDS in 98% of the cases. Meningeal compromise was seen in 90% of the patients. Although cerebrospinal fluid rendered more positive results, blood culture was the first diagnostic finding in some cases. Cryptococcal antigen showed positive results in 96.2% of the sera samples and in the 93.1% of the cerebrospinal fluid samples. Most of the isolates were Cryptococcus neoformans and belonged to genotype VNI. Minimal inhibitory concentration values were mostly below the epidemiological cutoff values. Conclusions. We observed that thanks to a high level of clinical suspicion, early diagnosis, combined therapy and intracranial pressure control by daily lumbar punctures, the global mortality rate has markedly decreased through the years in the analyzed period (AU)


Antecedentes. La criptococosis es una micosis grave y un motivo de preocupación en América Latina, en especial en los pacientes positivos para el VIH. Sin embargo, no existen aún datos regionales fiables acerca de la prevalencia de la enfermedad. Objetivos. Presentar los datos de 2.041 pacientes con criptococosis atendidos en la Unidad de Micología del Hospital de Infecciosas F. J. Muñiz de Buenos Aires, recogidos en un período de 30 años. Métodos. Se presentan datos demográficos, diagnósticos, clínicos y el tiempo de supervivencia de los pacientes, obtenidos de la base de datos de la Unidad de Micología. Se realizaron exámenes micológicos de diversas muestras clínicas, además de antigenemia y antigenorraquia por aglutinación de látex para Cryptococcus en el momento del diagnóstico y durante el seguimiento. Se llevó a cabo la identificación fenotípica de los aislamientos y en numerosos casos también se efectuó la genotipificación. La determinación de los valores de concentración mínima inhibitoria frente a diversos antifúngicos se realizó según el documento M27-A3 (CLSI). Resultados. El 75% de los pacientes positivos para el VIH y el 50% de los no portadores eran varones; la media de edad fue 34,1 años para los positivos para el VIH y 44,8 para los no portadores. La criptococosis se asoció con el sida en el 98% de los casos y el 90% de ellos presentó compromiso meníngeo. Aunque la muestra clínica con mayor porcentaje de resultados positivos fue el LCR, en numerosas ocasiones el hemocultivo fue el primer elemento diagnóstico. La antigenemia fue positiva en el 96,2% de los casos y la antigenorraquia en el 93,1%. La mayor parte de las cepas era Cryptococcus neoformans y pertenecía al genotipo VNI, y la concentración mínima inhibitoria en las pruebas de sensibilidad a los antifúngicos de la mayoría de ellos mostró valores inferiores al punto de corte epidemiológico. Conclusiones. Observamos que un alto nivel de sospecha clínica, el diagnóstico temprano, el tratamiento combinado y el control de la presión intracraneal mediante punciones lumbares diarias han permitido disminuir la mortalidad global a lo largo de los años en el período analizado (AU)


Humans , Cryptococcus/isolation & purification , Cryptococcosis/epidemiology , Antifungal Agents/therapeutic use , AIDS-Related Opportunistic Infections/epidemiology , HIV Infections/complications , Early Diagnosis , Intracranial Hypertension/diagnosis , Spinal Puncture , Mycological Typing Techniques , Argentina/epidemiology
20.
Rev. iberoam. micol ; 35(1): 56-58, ene.-mar. 2018. ilus
Article Es | IBECS | ID: ibc-170923

No disponible


A 48 year-old immunocompetent woman, who had a nodular lesion in the neck and a dense infiltrate at the lower lobe of the left lung, presented at the Mycology Unit of Muñiz Hospital of Buenos Aires City. The pulmonary infiltrate disappeared spontaneously 3 months later. The histopathological study of the nodular lesion showed capsulated yeasts (mucicarmin and alcian blue positive stains) compatible with Cryptococcus. The mycological study of a new sample, obtained by a nodular puncture, allowed the isolation of yeasts, identified as Cryptococcus gattii (VGII). Latex test for Cryptococcus capsular antigen in serum was positive (1/100). CSF cultures rendered negative results. Fluconazole at a daily dose of 800mg was given during 45 days with partial improvement; as cultures from a new clinical sample were positive for Cryptococcus, the antimycotic was changed to itraconazole 400mg/day for 5 months, with an excellent clinical response (AU)


Humans , Female , Middle Aged , Cryptococcus gattii/isolation & purification , Cryptococcosis/microbiology , Lung Diseases, Fungal/microbiology , Fluconazole/therapeutic use , Chromatography, Affinity , Latex Fixation Tests
...